← 483 OBSERVATION EXPLORER

FDA 483 OBSERVATION · #761 OF 1,000 MOST-CITED

Cleaning SOPs/equipment protection

FDA cited this observation 21 times across 21 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Drugs21
BY FISCAL YEAR
FY20261
FY20251
FY20244
FY20231
FY20224
FY20211
FY20202
FY20193
FY20182
FY20172

How FDA worded it — real examples

Procedures for the cleaning and maintenance of equipment are deficient regarding the protection of clean equipment from contamination prior to use.

Dabur India Limited · Dadra And Nagar Haveli · Drugs · 2026-01-16

Procedures for the cleaning and maintenance of equipment are deficient regarding the protection of clean equipment from contamination prior to use.

China Ningbo Shangge Cosmetic Technology Corp. · Ningbo · Drugs · 2025-03-14

Procedures for the cleaning and maintenance of equipment are deficient regarding the protection of clean equipment from contamination prior to use.

Right Value Drug Stores LLC · Irving, Texas · Drugs · 2024-06-21

Procedures for the cleaning and maintenance of equipment are deficient regarding the protection of clean equipment from contamination prior to use.

Outin Futures Corp · Chungju · Drugs · 2024-03-29

Procedures for the cleaning and maintenance of equipment are deficient regarding the protection of clean equipment from contamination prior to use.

Natures Formulae Health Products Ltd. · Kelowna · Drugs · 2023-11-03

Procedures for the cleaning and maintenance of equipment are deficient regarding the protection of clean equipment from contamination prior to use.

MARY KAY INC. · Lewisville, Texas · Drugs · 2023-10-27

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Cleaning validationPharma industry

Examples are a representative sample of FDA's published inspection observations. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →